Imperial College London

Professor Axel Behrens, Scientific Director of the Cancer Research UK Convergence Science Centre, has been awarded a prestigious Fellowship by the Academy of Medical Sciences, recognizing his contributions to cancer stem cell biology and multidisciplinary research.

Novo Nordisk's GLP-1 drugs semaglutide and liraglutide show potential in reducing Alzheimer's risk and cognitive decline, with semaglutide linked to a 40-70% reduction in Alzheimer's risk in type 2 diabetes patients. Novo's Phase III EVOKE and EVOKE Plus trials, expected in 2025, aim to further test semaglutide's efficacy in Alzheimer's patients.

Managers to be legally accountable for patient safety; flu admissions surge; nursing faces 'perfect storm'; third of mothers struggle during labor; families criticize disgraced surgeon review; unbearable heat in maternity wards; privacy fears deter prisoners from healthcare; watchdog examines medication issues in A&E; HSSIB offers After Action Review webinar; Clinical Human Factors Group announces SEIPS masterclass; Patient Safety APPG update; National State of Patient Safety 2024 report to be published.

Research from Imperial College London shows nut allergens don't circulate in aircraft ventilation systems, and allergic reactions are less common during flights. Cleaning seat areas is crucial, and allowing food-allergic passengers to board early can help. The study aims to influence airline policies for food-allergic passengers.

Women's underrepresentation in healthcare research leads to misdiagnoses, lack of effective treatments, and systemic neglect, particularly impacting women of color. Equal acknowledgment and inclusion in medical research are crucial for improving women's health outcomes.

Siemens Healthineers introduces Acuson Sequoia 3.5, an AI-powered update enhancing workflow and clinical performance with features like AI Abdomen reducing sonographer hand motion by up to 89%. The update also includes new breast and MSK imaging solutions, and the HLX transducer for improved resolution and ergonomics. Acuson Sequoia 3.5 is FDA-cleared and CE marked, available globally.

Albus Health's AI-powered device detects child asthma attacks up to 5 days before onset, potentially transforming respiratory care by enabling early intervention.

Wes Streeting MP and Peter Kyle MP unveiled a new total-body PET scanner at St Thomas’ Hospital, which is 5 times more sensitive and 2-4 times faster, aiding quicker diagnoses and detailed whole-body readings. Managed by King’s and Imperial College London, it feeds into the National PET Imaging Platform, improving disease understanding and medicine development. The scanner benefits patients like Sarah Corfield, who found it less claustrophobic and quicker. Both secretaries praised the scanner for its potential to save lives through earlier detection and faster diagnoses.

A new total-body PET scanner, 40 times more sensitive and 10 times faster, unveiled at St Thomas’ Hospital. It supports the National PET Imaging Platform, aiding faster diagnosis and treatment of diseases like cancer. Patient Sarah Corfield praised the scanner's comfort and speed. The scanner will feed into NPIP, building a UK-wide bank of medical research findings.

Men with CVD risk factors experience cognitive decline a decade earlier than women, per a study by Imperial College London and Cardiff University. The research, based on 34,425 UK Biobank participants, found significant brain health deterioration in men from mid-50s to mid-70s, while women are most vulnerable from mid-60s to mid-70s. The study highlights that cardiovascular risk impacts cognitive functions independently of genetic predisposition.